Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CK18-Fragments as Tools for Evaluating Diagnosis, Biological Activity, and Prognosis of Graft-Versus-Host Disease

NCT00935324 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT00935324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00935324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CK18-Fragments as Tools for Evaluating Diagnosis, Biological Activity, and Prognosis of Graft-Versus-Host Disease
Lead sponsor
Heidelberg University
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2009
Completion date
May 31, 2011
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allo-sct